Additionally, elevated HE4 were linked to more aggressive pathological features in patients with concurrent EC, including deeper myometrial invasion, MELF positivity, larger tumor size, and the diagnosis of intermediate-high-risk EC. This evidence concerns the gene WFDC2 and neoplasm.